RBM29 Antibodies

Santa Cruz Biotechnology delivers a wide array of RBM29 monoclonal antibodies for research focused on understanding RNA Binding Motif Protein 29 (RBM29). RBM29 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RBM29, or RNA Binding Motif Protein 29, plays an essential role in regulating gene expression and RNA processing through its involvement in splicing and mRNA stability mechanisms. Current research indicates RBM29's significance in various diseases, particularly cancer and neurodegenerative disorders. Investigating RBM29 function provides valuable insights into the molecular pathways that influence disease development and progression. Understanding RBM29's role in RNA processing can reveal new therapeutic targets and treatment strategies. Ongoing studies continue to uncover novel aspects of RBM29's cellular functions and disease associations. Santa Cruz Biotechnology monoclonal antibodies for RBM29 support researchers worldwide in advancing scientific understanding of RNA biology and disease mechanisms.